CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Hamps Bio Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Hamps Bio Ltd
Phone: +91 8000006663p:+91 8000006663 SURAT, 395009  India Ticker: 544312544312
Business Summary
Hamps Bio Limited is an India-based company, which is engaged in pharmaceutical formulation and freeze-drying ingredient manufacturing and distributing. Its products include home pharmaceutical products and freeze-drying food products. Its home pharmaceutical products include antibiotic/antibacterial/antifungal; hematantic/calcium supplement; painkiller/ anti-inflammatory; antiacid/PPI; mouth wash; toothpaste; pediatric care; nutrition supplement, and injections. Its freeze-drying food products include ingredients for fruit tea / traditional tea; ingredients for fruit snacks / juice powder/ smoothie mix / ice cream; ingredients for noodles / instant food / ready to eat; ingredients for super food, and application like camel milk / curd / panner/ cheese / cow colostrum. Its injection products include ALLSEF; Beep 40; BMXCLAV; PTSEFT; SEFTZONE-1.5GM, and others. Its ingredients for super food include prickly pear, beet, spinach, noni, garcinia cambochia, and more.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/20243/31/2024Yes----

Industries
SIC Code Description
5122 Drugs, drug proprietaries, and druggists' sundries
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Managing Director, Executive Chairman of the Board Herrik M.Shah 43 11/4/2023 11/4/2023
Chief Financial Officer MitaliShah 38 6/14/2024 12/11/2023
Compliance Officer, Company Secretary KomalJain 32 12/1/2023 12/1/2023
9 additional Officers and Directors records available in full report.

General Information
Number of Employees: 73 (As of 6/30/2024)
Outstanding Shares: 4,356,000 (As of 3/31/2024)
Stock Exchange: BOM


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, January 20, 2025